Comerica Bank’s ALX Oncology ALXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-411
Closed -$2.48K 3674
2024
Q2
$2.48K Sell
411
-45
-10% -$553 ﹤0.01% 3453
2024
Q1
$5.08K Hold
456
﹤0.01% 3337
2023
Q4
$6.79K Sell
456
-232
-34% -$2.2K ﹤0.01% 3242
2023
Q3
$3.3K Buy
+688
New +$3.73K ﹤0.01% 3470

Other funds holding ALXO

Comerica Bank's ALXO Position: Q3 2024 in Review

Comerica Bank sold out of ALX Oncology (ALXO) in Q3 2024, closing a stake of 411 shares — an estimated $2.48K sold.

Comerica Bank first reported a position in ALXO in Q3 2023 and held it in 4 quarters. The position peaked at $6.79K in Q4 2023. 92 funds tracked by Wall St. Rank hold ALXO as of Q3 2024.

  • Comerica Bank reported no remaining ALX Oncology position as of Q3 2024 after selling out during the quarter.
  • Comerica Bank sold 411 ALX Oncology shares in Q3 2024, an estimated $2.48K.
  • Comerica Bank first reported a position in ALX Oncology in Q3 2023 and held it in 4 quarters.
  • Comerica Bank's ALX Oncology position peaked at $6.79K in Q4 2023.
  • 92 funds tracked by Wall St. Rank held ALX Oncology as of Q3 2024.

Based on Comerica Bank's 13F filing for Q3 2024, filed 14 Nov 2024.